Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% | 0.00% | 0.00% |
2015 | MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2014 | MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application | CI |
Sales 2013 | 49.32K 67.5K | Sales 2014 | 49.32K 67.5K | Capitalization | 2.16M 2.96M |
---|---|---|---|---|---|
Net income 2013 | -1M -1.37M | Net income 2014 | - 0 | EV / Sales 2013 | 34.9 x |
Net cash position 2013 | 39.11K 53.53K | Net Debt 2014 | 90.04K 123K | EV / Sales 2014 | 45.7 x |
P/E ratio 2013 |
-1.09
x | P/E ratio 2014 |
-4.9
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 90.01% |
1 day | -90.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.000001 | -90.00% | 450,000 |
24-05-08 | 0.00001 | +900.00% | 200,000 |
24-05-06 | 0.000001 | 0.00% | 1,581,688 |
24-05-02 | 0.000001 | 0.00% | 3,000 |
24-05-01 | 0.000001 | 0.00% | 130,000 |
Delayed Quote OTC Markets, May 09, 2024 at 01:02 pm
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 5K | |
+23.37% | 47.02B | |
+48.83% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- MCET Stock